Chat with us, powered by LiveChat

Sindusfarma Workshop: Risk Assessment of the presence of Nitrosamines in IFAs and Medicines

We were pleased to join Sindusfarma for an online workshop to discuss how to perform Step 1 of the Nitrosamines Risk Assessment.

The objective of this workshop was to present the concepts and practical aspects on the risk assessment of the presence of nitrosamines in Active Pharmaceutical Inputs (IFAs) and Medicines, considering the publication of RDC 677/2022 and Guide No. 50, version 2.

Principal Application Scientist, Fernanda Waechter, delivered a presentation during the workshop.